Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

EHTH vs SLQT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

EHTH Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 6–4 Matrix Metrics)

EHTH Overall Winner 6-Pillar Tally: EHTH 3 – 3 SLQT Matrix Metrics: EHTH 6 – 4 SLQT

As of Nov 17, 2026, eHealth, Inc. (EHTH) is the stronger overall head-to-head candidate over SelectQuote, Inc. (SLQT) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). EHTH carries a Unified Composite Score of 40.8/100 (SELL) at $0.35 (0.2x Forward P/E, 11.9% operating margin), whereas SLQT carries 30.0/100 (SELL) at $6.65 (66.7x Forward P/E, 5.5% operating margin).

  • Growth vs. Quality Trade-Off: EHTH earns the overall head-to-head edge with a stronger Unified Composite Score (40.8/100 SELL vs. SLQT 30.0/100 SELL) and 1.61β · 117% Vol risk profile, whereas SLQT leads top-line expansion (-14.8% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
  • Defensive Composite Rating Caution: Although EHTH compares more favorably head-to-head, both EHTH (40.8/100 SELL) and SLQT (30.0/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: EHTH is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.9); meanwhile SLQT trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 96.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About EHTH vs SLQT
EHTH NASDAQ Head-to-Head Winner
eHealth, Inc.
Insurance Agents, Brokers & Service
$0.35
-9.36% 1D
Market Cap $13.4M
TTM Revenue $469M
Forward P/E 0.2x
Beta / 30D Vol 1.61β · 117% Vol
Unified Composite Score
40.8 / 100 SELL
Tech 25.0 Fund 44.0 Flow 50.0 Mom 63.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -28.4%), weak momentum, RSI 25
RSI-14: 24.9 · SMA20: $0.50 · SMA50: $0.65
SLQT NYSE
SelectQuote, Inc.
Insurance Agents, Brokers & Service
$6.65
+1650.0% 1D
Market Cap $79.3M
TTM Revenue $1.57B
Forward P/E 66.7x
Beta / 30D Vol -11.69β · 5789% Vol
Unified Composite Score
30.0 / 100 SELL
Tech 5.0 Fund 27.0 Flow 66.0 Mom 11.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (6.3% over 20 days), RSI 97
RSI-14: 96.6 · SMA20: $0.73 · SMA50: $0.54

6-Pillar Scorecard Institutional Category Breakdown (EHTH 3 – 3 SLQT)

Columns: Metric · EHTH · SLQT
1. Valuation Multiples EHTH
Forward P/E 0.2x 66.7x
Trailing P/E 0.2x 66.7x
PEG Ratio 0.72x N/M
EV / Revenue N/M 0.3x
2. Growth & Scale SLQT
Revenue Growth (YoY) -60.5% -14.8%
Earnings Growth (YoY) -17.6% +219.2%
TTM Revenue (USD) $469M $1.57B
Market Cap $13.4M $79.3M
3. Profitability & Quality EHTH
Gross Margin 100.0% 36.4%
Operating Margin 11.9% 5.5%
Net Profit Margin 4.9% 4.6%
Return on Equity (ROE) 2.6% 12.3%
4. Balance Sheet & Cash Flow EHTH
Cash Generation (TTM) $58M EBITDA $16M
Cash Flow Margin 12.4% EBITDA Mgn 1.0%
Net Cash / Leverage $15.36 Book/Sh · 2.6% ROE $380M Net Debt (0.61x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning SLQT
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 128.7% (56th %ile) 301.9% (100th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markup
6. R&D & Supply-Chain Moat SLQT
OpEx & R&D Intensity N/A 30.9% of Rev ($485M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Insurance Brokers Operator Insurance Brokers Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: EHTH (6) vs SLQT (4)
Institutional Metric EHTH SLQT Criterion Row Edge
Market Capitalization
Scale
$13.4M $79.3M Larger Scale SLQT
Trailing P/E Ratio
Valuation
0.2x 66.7x Lower Multiple EHTH
Forward P/E Ratio
Valuation
0.2x 66.7x Lower Multiple EHTH
Revenue Growth (YoY)
Growth
-60.5% -14.8% Higher Growth SLQT
Operating Margin (TTM)
Profitability
11.9% 5.5% Higher Margin EHTH
Net Profit Margin
Profitability
4.9% 4.6% Higher Margin EHTH
Return on Equity (ROE)
Capital Efficiency
2.6% 12.3% Higher ROE SLQT
52-Week Range Position
Momentum
0% ($0–$5) 82% ($0–$8) Stronger Trend SLQT
Beta / 30D Volatility
Risk Regime
1.61β · 117% Vol -11.69β · 5789% Vol Lower Realized Risk EHTH
Unified Institutional Score
Composite Signal
40.8 / 100 (SELL) 30.0 / 100 (SELL) Higher Composite EHTH
Trailing 12M Revenue (USD)
Operating Scale
$469M $1.57B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
100.0% 36.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.72x PEG · N/M EV/Rev N/M PEG · 0.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$58M EBITDA ($15.36 Book/Sh · 2.6% ROE) $16M ($380M Net Debt (0.61x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SLQT +2035.76 pp
EHTH: -38.63% · SLQT: +1997.13%
3M Horizon SLQT +828.0 pp
EHTH: -72.03% · SLQT: +755.97%
6M Horizon SLQT +625.93 pp
EHTH: -80.3% · SLQT: +545.63%
1Y Horizon SLQT +437.23 pp
EHTH: -90.92% · SLQT: +346.31%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EHTH vs SLQT. Trailing 12-month operating profitability (EHTH 11.9% vs SLQT 5.5%) and valuation multiples (EHTH 0.2x vs SLQT 66.7x Forward P/E) are benchmarked directly in Pillar 4 below.

EHTH ADR TTM Benchmark FX-Normalized USD
TTM Revenue$469M
Gross Margin100.0%
Op. Margin11.9%
ROE / Fwd P/E2.6% · 0.2x
SLQT ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.57B
Gross Margin36.4%
Op. Margin5.5%
ROE / Fwd P/E12.3% · 66.7x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
EHTH UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 128.7%
IV Percentile 56th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact EHTH Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SLQT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 301.9%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact SLQT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
EHTH Moat Profile Cyclical / Execution-Driven Positioning
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $13.4M market capitalization and 11.9% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
SLQT Moat Profile Cyclical / Execution-Driven Positioning
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $79.3M market capitalization and 5.5% operating margin.
OpEx & R&D Reinvestment 30.9% of Rev ($485M)
90D Engineering Disclosures 0 Published

Investor FAQ EHTH vs SLQT Key Questions & Quantitative Answers

As of Nov 17, 2026, eHealth, Inc. (EHTH) is the stronger overall head-to-head candidate over SelectQuote, Inc. (SLQT) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). EHTH carries a Unified Composite Score of 40.8/100 (SELL) at $0.35 (0.2x Forward P/E, 11.9% operating margin), whereas SLQT carries 30.0/100 (SELL) at $6.65 (66.7x Forward P/E, 5.5% operating margin). Growth vs. Quality Trade-Off: EHTH earns the overall head-to-head edge with a stronger Unified Composite Score (40.8/100 SELL vs. SLQT 30.0/100 SELL) and 1.61β · 117% Vol risk profile, whereas SLQT leads top-line expansion (-14.8% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Defensive Composite Rating Caution: Although EHTH compares more favorably head-to-head, both EHTH (40.8/100 SELL) and SLQT (30.0/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: EHTH is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.9); meanwhile SLQT trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 96.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SLQT leads the Growth & Scale pillar: EHTH posts -60.5% YoY revenue growth and -17.6% YoY earnings growth on $469M TTM revenue (100.0% gross margin, 11.9% operating margin), compared with SLQT at -14.8% YoY revenue growth and +219.2% YoY earnings growth on $1.57B TTM revenue (36.4% gross margin, 5.5% operating margin). On trailing 12-month operating scale, EHTH generates $469M in USD-normalized revenue versus $1.57B for SLQT. In operating R&D and SG&A reinvestment, EHTH deploys N/A (0 90-day corporate R&D disclosures) versus 30.9% of Rev ($485M) (0 disclosures) for SLQT.

EHTH screens cheaper on headline valuation multiples. EHTH trades at 0.2x Forward P/E, 0.2x Trailing P/E, 0.72x PEG, and N/M EV/Revenue (12.4% EBITDA margin), whereas SLQT trades at 66.7x Forward P/E, 66.7x Trailing P/E, N/M PEG, and 0.3x EV/Revenue (1.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EHTH (2.6% ROE) versus SLQT (12.3% ROE) capital efficiency.

In options market volatility and institutional positioning, EHTH carries 128.7% implied volatility (56th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.61β · 117% Vol realized risk). By comparison, SLQT carries 301.9% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-11.69β · 5789% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.